|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.99 EGP | 0.00% |
|
-3.86% | +20.61% |
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EGP 1,246.43 million compared to EGP 960.17 million a year ago. Net income was EGP 181.09 million compared to EGP 112.18 million a year ago.
Basic earnings per share from continuing operations was EGP 0.1664 compared to EGP 0.0975 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +20.61% | 63.04M | |
| +31.06% | 682B | |
| +30.35% | 586B | |
| -3.42% | 364B | |
| +18.02% | 327B | |
| +4.27% | 285B | |
| +15.53% | 240B | |
| +10.16% | 209B | |
| -8.14% | 203B | |
| +8.12% | 165B |
TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) S.A.E. 